Antibiotic Treatment Of Male Partners To Reduce Recurrence Of Bacterial Vaginosis In Women: A Randomised Double-blind Controlled Trial
Funder
National Health and Medical Research Council
Funding Amount
$636,674.00
Summary
Bacterial vaginosis (BV) is the most common vaginal infection in women. Healthy bacteria are lost and replaced by bacteria that cause unpleasant discharge and odour. BV puts women at increased risk of sexually transmitted infections, HIV, miscarriage and preterm delivery. Over 50% of women given antibiotics get BV back again. Studies suggest these bacteria are being sexually transmitted. We are conducting a trial of antibiotic treatment of women and their male partners to improve BV cure.
Strengthening Frontline Clinicians’ Infection Control: A Multi-method Study To Reduce MRSA Infection And Transmission
Funder
National Health and Medical Research Council
Funding Amount
$800,339.00
Summary
Despite handwashing initiatives and the introduction of alcohol gels, cross-infection in hospitals remains a terrible risk for patients and creates a huge cost for health care funders. This study deploys a video-based technique called video reflexivity to alert frontline clinicians to the infection risks that are inherent in their every practice, educating them to become smarter about such risk.
The Role Of Perivascular Macrophages In The Regulation Of Skin Inflammation
Funder
National Health and Medical Research Council
Funding Amount
$616,518.00
Summary
Neutrophils are key defenders against bacterial infections. In this application we will test the hypothesis that perivascular macrophages play a critical role in the recruitment of neutrophils to site of cutaneous infection, and that these cells are targeted and destroyed by bacterial virulence factors. Our studies will gain novel insight into the leukocyte homing paradigm and shed new light on the mechanisms of microbial immuno-evasion.
Star Polymers As Novel Antimicrobial And Immunomodulatory Agents
Funder
National Health and Medical Research Council
Funding Amount
$945,908.00
Summary
The rise in antibiotic resistance in bacteria is considered as a major public health threat that is not being met by antibiotic research. This project will modify a novel star polymer that we have shown kills antibiotic resistant bacteria but does not induce resistance. The project will make and characterise new versions of the star polymer to produce antimicrobial materials that target and kill the multi-drug resistant bacteria that are a major cause of bacterial infections and death.
Legionella bacteria are the major cause of Legionnaire’s Disease, a common form of acute pneumonia. Here we will study how the bacteria avoid killing in human cells by establishing an intracellular niche that is sequestered from the normal host cell defence pathways. In particular we hope to understand how the bacteria regulate a major protein modification pathway called ubiquitination.
Multiple Antibiotic Resistance In An Acinetobacter Baumannii Global Clone
Funder
National Health and Medical Research Council
Funding Amount
$606,580.00
Summary
Antibiotic resistant bacteria that cause infections in hospitals can originate anywhere, then spread world wide. They start off resistant to a few antibiotics, then become resistant to new antibiotics that are introduced to treat them. This project will investigate how resistance to antibiotics was acquired by Acinetobacter baumannii which is now resistant to most antibiotics, and why the old resistance genes are not being lost. This will help track these bacteria moving into and around Australi ....Antibiotic resistant bacteria that cause infections in hospitals can originate anywhere, then spread world wide. They start off resistant to a few antibiotics, then become resistant to new antibiotics that are introduced to treat them. This project will investigate how resistance to antibiotics was acquired by Acinetobacter baumannii which is now resistant to most antibiotics, and why the old resistance genes are not being lost. This will help track these bacteria moving into and around Australia.Read moreRead less
The Efficacy Of Mass Drug Administration Strategies To Control Scabies In A Highly Endemic Population.
Funder
National Health and Medical Research Council
Funding Amount
$705,396.00
Summary
Globally there are an estimated 300 million scabies cases annually. Many Pacific countries, including Fiji, have among the highest rates in the world. This island based study in Fiji will compare the short and long term efficacy of two mass treatment protocols using oral ivermectin or topical permethrin against conventional treatment. This study will be the first population-wide treatment trial for scabies that compares new interventions to standard of care treatment.
E. coli is a normal inhabitant of the human intestine, but some varieties can cause serious infections that may lead to the premature death of children, especially in less developed countries. The aims of this study are to learn more about these harmful varieties of E. coli and to enhance our ability to detect them in samples from patients and the environment.
A New Genomic Frontier For Foodborne Disease Investigation In Australia
Funder
National Health and Medical Research Council
Funding Amount
$750,520.00
Summary
Foodborne diseases caused by bacteria such as Salmonella and Campylobacter are a huge public health problem, both in Australia and globally. Current methods used to investigate foodborne disease may not be sensitive enough to track foodborne outbreaks, and may not even detect them in the first place. We propose using cutting-edge molecular techniques to investigate foodborne outbreaks, and we think that using these methods will enable outbreaks to be interrupted at a much earlier stage.
The Role Of The Chemosensory Receptors Of The Enteric Pathogen C. Jejuni In Virulence And Host - Bacterial Interactions
Funder
National Health and Medical Research Council
Funding Amount
$517,897.00
Summary
Campylobacter jejuni is the greatest cause of bacterial gastroenteritis in the world. Consumption of contaminated meat or untreated water leads to disease often requiring hospitalisation. Campylobacter infection is also linked to the development of neoroparalytic disorders and reactive arthritis. This project aims to determine how this pathogen utilises surface molecules to sense its environment and cause disease. This information may be exploited to develop new treatments for mucosal infections ....Campylobacter jejuni is the greatest cause of bacterial gastroenteritis in the world. Consumption of contaminated meat or untreated water leads to disease often requiring hospitalisation. Campylobacter infection is also linked to the development of neoroparalytic disorders and reactive arthritis. This project aims to determine how this pathogen utilises surface molecules to sense its environment and cause disease. This information may be exploited to develop new treatments for mucosal infections.Read moreRead less